Westford, MA, United States of America

Scott Michael Lonning

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Scott Michael Lonning: Innovator in Antibody Therapeutics

Introduction

Scott Michael Lonning is a prominent inventor based in Westford, MA (US), known for his significant contributions to the field of antibody therapeutics. With a total of 14 patents to his name, Lonning has made remarkable advancements in the development of innovative treatments.

Latest Patents

Among his latest patents are the "Anti-VTCN1 antibodies and antibody drug conjugates," which disclose anti-V-set domain containing T cell activation inhibitor 1 (VTCN1) antibodies and antibody drug conjugates (ADCs). These patents include compositions and methods for utilizing these antibodies and ADCs effectively. Another notable patent is for "Nucleic acids encoding anti-IL1RAP antibodies and their uses," which details Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and ADCs, along with their compositions and methods of application.

Career Highlights

Scott Michael Lonning is currently associated with Bluefin Biomedicine, Inc., where he continues to push the boundaries of medical science through his innovative research and development efforts. His work focuses on creating effective antibody-based therapies that have the potential to transform treatment options for various diseases.

Collaborations

Lonning collaborates with talented professionals in his field, including Nels Eric Pederson and Klarisa Rikova, who contribute to the advancement of his research initiatives.

Conclusion

Scott Michael Lonning stands out as a key figure in the realm of antibody therapeutics, with a strong portfolio of patents that reflect his dedication to innovation. His work at Bluefin Biomedicine, Inc. continues to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…